CR with added BWLT for Obesity

University of Calgary, Calgary, Canada
Obesity+1 More ConditionsCR with added BWLT - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial will test whether adding behavioral weight-loss treatment to traditional cardiac rehabilitation helps people with atrial fibrillation and obesity experience relief from their symptoms.

Eligible Conditions
  • Obesity
  • Atrial Fibrillation

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

2 Primary · 4 Secondary · Reporting Duration: Baseline, 12-weeks

Baseline, 12-weeks
Atrial Fibrillation
Post-intervention (12 weeks)
Intervention Acceptability
Intervention Feasibility
baseline, 12-weeks
AF-related quality of life
Psychological Distress
Weight Loss

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

1 of 1

Experimental Treatment

14 Total Participants · 1 Treatment Group

Primary Treatment: CR with added BWLT · No Placebo Group · N/A

Experimental Group · 1 Intervention: CR with added BWLT · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 12-weeks

Who is running the clinical trial?

University of CalgaryLead Sponsor
727 Previous Clinical Trials
573,564 Total Patients Enrolled
14 Trials studying Obesity
1,154 Patients Enrolled for Obesity

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a body mass index (BMI) of 30 or higher, which means you are overweight.

Frequently Asked Questions

For what size of participant pool is this trial recruiting?

"Affirmative, reports that this trial is currently accepting recruits. This research project was first posted on January 24th 2022 and underwent its last update in October 2021. A total of 40 volunteers will be taken from a single medical site for the study's duration." - Anonymous Online Contributor

Unverified Answer

Is the medical research currently seeking participants?

"Affirmative, the information provided on states that this research trial is actively recruiting participants. The project commenced on January 24th 2022 and was most recently amended in October 31st 2022. 40 people are needed to enroll from one centre." - Anonymous Online Contributor

Unverified Answer

What are the research goals of this investigation?

"This medical trial is expected to last 12 weeks, its primary objective being the evaluation of Intervention Feasibility. Secondary goals include evaluating Atrial Fibrillation Effect on Quality-of-Life Questionnaire (AFEQT), Beck Depression Inventory - II (BDI - II) and Beck Anxiety Inventory (BAI) scores for symptoms of Psychological Distress along with University Of Toronto AF Symptom Severity Scale (AFSS). The assessments will measure changes in patient's quality of life over time as well as global wellbeing." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.